Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2023/09/057492
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Onset of arthritis after the age of 16 years
Positive for rheumatoid factor (RF)
Anti - CCP
Either an erythrocyte sedimentation rate (ESR) of greater than 30 mm/hr OR
C-reactive protein level greater than 1.0 mg/dl (normal less than 0.4)
Diagnosis of Uthira Vatha Suronitham, as defined by fulfilling at least more than two articular involvements
Minor
Morning stiffness
Willing to take study medication
Willing to follow diet restriction
Patients giving informed consent (Signed or oral witnessed, according to local regulations) before any Protocol specific
procedures.
Uncontrolled Diabetes Mellitus
Uncontrolled Hypertension
Cardiac disease
Renal disease
Neurological disorders
Pregnancy and lactation
History of alcohol or substance abuse
Active infection, or chronic or persistent infection that might
worsen with immunosuppressive treatment
Patients who have already participated in a new drug study in
the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of pain and swelling of the jointsTimepoint: Baseline and 12 th week
- Secondary Outcome Measures
Name Time Method To study the clinical laboratory parameters related to RA RA Factor CRP ESR etcTimepoint: Baseline ad 12th wek